I happened to see this article this morning and found it both interesting and alarming. Here’s the gist of the article in quotes. The date of the article is 5/21/21.
————
full article
https://www.oann.com/india-faces-antifungal-drug-shortage-as-rare-complication-adds-to-covid-19-woes/“Cases of mucormycosis, or “black fungus,” a potentially serious condition that causes blurred or double vision, chest pain and breathing difficulties, have surged in India, mostly among COVID-19 patients.
At least 7,250 such cases have been found across the country as of May 19, local media reported.
“In this battle of ours, another new challenge of black fungus has also emerged these days,” Prime Minister Narendra Modi tweeted on Friday.
India has the second-highest tally of confirmed COVID-19 cases in the world and has been reporting some 250,000 infections and 4,000 deaths daily.
With mucormycosis cases rising, India’s health ministry said it was looking for more companies to produce the antifungal drug amphotericin B used to treat it and also increase imports of the medication.”
——————
What This Could Mean For Us:
1. Possible difficulty getting Amphotericin-B
(I have a fairly recent prescript
ion that I didn’t get filled.)
2. Those who get COVID, have long COVID, or who have ever had COVID could be more susceptible to mold and fungal illness and biotoxin illness from exposure to water damaged buildings